Jen‐Shi Chen

Researcher Next ID · RN-014403

Researcher · Medicine

, Taiwan

Not currently recruitingFunding unknown

Research interests

Medicine

Palliative Care and End-of-Life Issues

Gastric Cancer Management and Outcomes

Cancer survivorship and care

Cholangiocarcinoma and Gallbladder Cancer Studies

Pancreatic and Hepatic Oncology Research

Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial
The Lancet · 2023 · 10.1016/s0140-6736(23)00727-4
Durvalumab plus Gemcitabine and Cisplatin in Advanced Biliary Tract Cancer
NEJM Evidence · 2022 · 10.1056/evidoa2200015
Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): a randomised, double-blind, placebo-controlled, phase 3 trial
The Lancet · 2017 · 10.1016/s0140-6736(17)31827-5
Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial
The Lancet · 2015 · 10.1016/s0140-6736(15)00986-1
Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors
New England Journal of Medicine · 2011 · 10.1056/nejmoa1003825

No projects listed.